FOLFIRINOX: a new standard of care in the adjuvant setting of resectable pancreatic adenocarcinomas

Future Oncol. 2019 Jun;15(17):1947-1950. doi: 10.2217/fon-2019-0136. Epub 2019 Jun 12.

Authors

Abdel Hadi Hajjar¹, Roland Eid¹, Fady Gh Haddad¹, Hampig Raphael Kourie¹

Affiliation

¹ Hematology & Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.

PMID: 31185748
DOI: 10.2217/fon-2019-0136

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adenocarcinoma*
Antineoplastic Combined Chemotherapy Protocols
Deoxycytidine / analogs & derivatives
Fluorouracil
Gemcitabine
Humans
Leucovorin
Pancreatic Neoplasms*
Standard of Care

Substances

Deoxycytidine
Leucovorin
Fluorouracil
Gemcitabine